Myomo Receives Accreditation from HQAAZiad Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Healthcare Quality Association on Accreditation (HQAA) has certified Myomo meets the accreditation requirements under the Social Security Act and federal regulations. Read more >>
For More Inclusivity In Wine, Our Language Needs to ChangeZiad ...As the wine world evolves to reach new generations and a wider range of people, so does the language used to describe it. Many have begun to break away from shared verbiage. “I grew up in Chicago, where there is no ‘forest floor,’” says Alicia Towns Franken, vice president of Archer Roose and head of mentorship at Wine Unify. “If we want more people to drink wine, we have to include them in the words we use to discuss wine.” Read...
Studies Show Sustained Acoustic Medicine Effectively Treats Shoulder InjuriesZiad Two recently published studies found that the long-duration, wearable sustained acoustic medicine device from ZetrOZ Systems relieves pain from shoulder and other injuries when conservative therapies fail, and can be a replacement for pain medications. Read more >>
Myomo, Inc. Announces Participation in A.G.P.’s Virtual MedTech Summer Conference on July 29, 2021Ziad Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will participate in A.G.P.’s Virtual MedTech Summer Conference on Thursday, July 29, 2021. Read more >>
First Light Diagnostics Receives FDA Clearance for its Rapid Clostridiodes difficile Test on the MultiPath® AnalyzerZiad First Light Diagnostics is developing and commercializing breakthrough automated diagnostic products for rapidly detecting infections and determining optimal treatment. The company announced today that the US Food and Drug Administration (FDA) has cleared its SensiTox™ C. difficile Toxin Test along with its proprietary MultiPath Analyzer to be marketed in the US. Read more >>
Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global ScaleZiad Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, today announced a commercial agreement with Seppic S.A., a supplier of specialty healthcare ingredients, for the supply of adjuvant for use in Akston’s COVID-19 Fc fusion protein vaccine candidate, AKS-452. Read more >>
Zylö Receives $1,700,000 NIH Phase II Grant to Advance Erectile Dysfunction Program into Human TrialsZiad Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, has been awarded a $1,700,000 Small Business Innovation Research (SBIR) grant to advance Zylö’s proprietary nitric-oxide-releasing topical drug candidate into clinical trials. Read more >>
Student Debt’s Devastating Impact on Retirement Saving: GRPAA ConferenceZiad Laurel Taylor, the founder of FutureFuel.io, began with a stark illustration surrounding student debt, a crushing issue with which many Americans currently wrestle. It wreaks havoc with so many other financial planning and saving goals, and she was called to address the problem due to personal experience. Read more >>